Summary
Definition
History and exam
Key diagnostic factors
- presencia de factores de riesgo
- disnea
- matidez a la percusión
Other diagnostic factors
- dolor torácico pleurítico
- tos
- ausencia o disminución de los ruidos respiratorios
- frémito táctil reducido o ausente
Risk factors
- insuficiencia cardíaca congestiva
- neumonía
- neoplasia maligna
- embolia pulmonar
- reciente injerto de derivación (bypass) de arterias coronarias
- reciente infarto agudo de miocardio
- enfermedad pulmonar laboral
- artritis reumatoide
- lupus eritematoso sistémico
- insuficiencia renal
- derrame pleural inducido por fármacos
- tratamiento reciente de estimulación ovárica
- quilotórax
Diagnostic investigations
1st investigations to order
- radiografía de tórax posteroanterior y lateral
- ultrasonido pleural
- niveles pleurales y séricos de lactato deshidrogenasa (LDH) y proteínas
- recuento de eritrocitos en el líquido pleural
- recuento de leucocitos y diagnóstico diferencial del líquido pleural
- citología del líquido pleural
- cultivo del líquido pleural
- pH del líquido pleural
- glucosa en el líquido pleural
- gradiente de proteínas
- hemograma completo (HC)
- proteína C-reactiva
- hemocultivo
- tinción de Gram y cultivo de esputo
- N-terminal del pro-péptido natriurético cerebral (NT-pro-BNP) en el líquido pleural
Investigations to consider
- nivel de colesterol en el líquido pleural
- exploración de tórax por tomografía computarizada (TC)
- imagen por resonancia magnética (IRM) torácica
- exploración por tomografía computarizada (TC) helicoidal
- amilasa en el líquido pleural
- nivel de adenosina desaminasa (ADA) en el líquido pleural
- análisis lipídico del líquido pleural
- análisis de anticuerpos antinucleares (ANA) del líquido pleural
- toracoscopia
- broncoscopia
- biopsia pleural
- interferón gamma en el líquido pleural y reacción en cadena de la polimerasa (PCR) en tiempo real del líquido pleural
- procalcitonina
Emerging tests
- marcadores tumorales en el líquido pleural
Treatment algorithm
insuficiencia cardíaca congestiva
derrame infeccioso
maligno: estado de rendimiento deficiente o vida útil limitada (puntuación de Karnofsky ≤30% o puntuación ECOG de ≥2)
maligno: buen estado general (puntuación de Karnofsky >30% o puntuación ECOG de 0 o 1)
empiema persistente a pesar del drenaje por tubo torácico
derrames malignos sintomáticos recurrentes
derrame benigno recurrente
Contributors
Authors
Orhan Orhan, MBBS, BSc, FRCP, SFHEA, MSc
Consultant Respiratory Physician
Chelsea and Westminster Hospital NHS Foundation Trust
London
UK
Disclosures
OO declares that he has no competing interests.
Acknowledgements
Dr Orhan Orhan would like to gratefully acknowledge Drs Clare Ross, Philip W. Ind, Anob M. Chakrabarti, Richard Light, Amber Degryse, Rachel J. Davies, and Peter M. George, previous contributors to this topic.
Disclosures
RL received speaking fees provided by Cardinal Health; owned stock in Denver Biomaterials until it was purchased by Cardinal Health; received fees for consulting from Denver Biomaterials; and is an author of references cited in this topic. CR, PWI, AMC, AD, RJD, and PMG declare that they have no competing interests.
Peer reviewers
Y.C. Gary Lee, MBChB, PhD, FCCP, FRACP
Consultant Chest Physician and Senior Lecturer
Oxford Centre for Respiratory Medicine and University of Oxford Churchill Hospital
Oxford
UK
Disclosures
YCGL declares that he has no competing interests.
Clare Hooper, MBBS
Pleural Research Registrar
North Bristol Lung Centre
Southmead Hospital
Westbury on Trym
Bristol
UK
Disclosures
CH declares that she has no competing interests.
Steven Sahn, MD
Professor of Medicine and Director
Division of Pulmonary/Critical Care/Allergy/Sleep Medicine
Medical University of South Carolina
Charleston
SC
Disclosures
SS declares that he has no competing interests.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
References
Key articles
Roberts ME, Rahman NM, Maskell NA, et al. British Thoracic Society guideline for pleural disease. Thorax. 2023 Jul;78(suppl 3):s1-42.Full text
Rahman NM, Maskell NA, West A, et al. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med. 2011 Aug 11;365(6):518-26. Abstract
Reference articles
A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
Differentials
- Engrosamiento pleural
- Oclusión y consolidación pulmonar
- Elevación del hemidiafragma
More DifferentialsGuidelines
- ACR appropriateness criteria: chronic dyspnea-noncardiovascular origin
- ACR appropriateness criteria: chylothorax treatment planning
More GuidelinesPatient information
Derrame pleural
More Patient informationVideos
Demostración animada de aspiración pleural
Demostración animada de la técnica de inserción de drenaje intercostal Seldinger
More videosLog in or subscribe to access all of BMJ Best Practice
Use of this content is subject to our disclaimer